Choriocarcinoma with uterine rupture presenting as acute haemoperitoneum and shock
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20170603Keywords:
Choriocarcinoma, Haemoperitoneum, Uterine ruptureAbstract
Choriocarcinoma is a rare neoplasm and a malignant form of gestational trophoblastic disease. Invasive mole may perforate uterus through the myometrium resulting in uterine perforation and intraperitoneal bleeding. But uterine perforation due to choriocarcinoma is rare. We present a case of a young woman who presented 1 year after uterine evacuation of a molar pregnancy with invasive choriocarcinoma complicated by a uterine rupture and haemoperitoneum.Metrics
References
Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev 2012.
Biscaro A, Braga A, Berkowitz RS. Diagnosis, classification and treatment of gestational trophoblastic neoplasia. Rev Bras Ginecol Obstet. 2015;37(1):42-51.
Lok CA, Ansink AC, Grootfaam D, van der Velden J, Verheijen RH, ten Kate-Booij MJ. Treatment and prognosis of post term choriocarcinoma in The Netherlands. Gynecologic Oncology. 2006;103:698-702.
Behtash N, Ansari S, Sarvi F. Successful pregnancy after localized resection of perforated uterus in choriocarcinoma and a literature review. Int Immuno J Gynecol Cancer. 2006;16:445-8.
Mackenzie F, Mathers A, Kennedy J. Invasive hydatidiform mole presenting as an acute primary haemoperitoneum. Br J Obstet Gynecol. 1993;100:953-4.
Agarwal M, Kumar R, Pyrbot J, Singh AS. Choriocarcinoma with Uterine Rupture and Shock: A Rare Case Report. Journal of Clinical and Diagnostic Research. 2015;9(10):ED20-ED1.
FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia. Int J Gynaecol Obstet. 2002;77:285-7.
Goto S, Ino K, Mitsui T, Kikkawa F, Suzuki T, Nomura S, et al. Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: effects of anti cancer agents on subsequent births. Gynecol Oncol. 2004;93:529-35.